For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Acetaminophen Intravenous | (group 1) 1 gram IV acetaminophen every 8 hours for three doses Acetaminophen Intravenous: IV 1 gram f3 doses over 24 hours | 0 | None | 0 | 47 | 0 | 47 | View |
| Acetaminophen Oral | (group 2) 1 gram oral acetaminophen every 8 hours for three doses Acetaminophen Oral: Oral 1 gram 3 doses over 24 hours | 0 | None | 0 | 47 | 0 | 47 | View |
| No Acetaminophen | (group 3) no acetaminophen | 0 | None | 0 | 47 | 0 | 47 | View |